Drugs / Human Granulocyte-Macrophage Colony-Stimulating Factor
Human Granulocyte-Macrophage Colony-Stimulating Factor
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT07342322 Background | Feb 2026 overdue | soft tissue sarcoma | First Affiliated Hospital of Guangxi Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human Granulocyte-Macrophage Colony-Stimulating Factor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07342322 ↗ |
| Modality | Protein / enzyme biologic | “recombinant human granulocyte-macrophage colony-stimulating factor injection” NCT07342322 ↗ |